Covered recipient · General Payments record
SAMUEL LEIBOVICI
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2018–2020
$590.05
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $200.92 | 11 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $63.64 | 3 |
| Lilly USA, LLC | $27.17 | 2 |
| Alkermes, Inc. | $23.99 | 1 |
| PFIZER INC. | $18.44 | 1 |
| Ultragenyx Pharmaceutical Inc. | $17.65 | 1 |
| GlaxoSmithKline, LLC. | $17.08 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.90 | 1 |
| Acerta Pharma LLC | $16.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $23.99 | 06/01/2020 | Food and Beverage | Undisputed | 01/23/2026 | 736974003 | CMS |
| Amgen Inc. | $23.38 | 09/08/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741299973 | CMS |
| Amgen Inc. | $16.17 | 10/26/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741299975 | CMS |
| Amgen Inc. | $24.09 | 11/18/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741299971 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.05 | 11/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | 736397513 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.90 | 01/22/2020 | Food and Beverage | Undisputed | 01/23/2026 | 727984915 | CMS |
| GlaxoSmithKline, LLC. | $17.08 | 02/11/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738515519 | CMS |
| Lilly USA, LLC | $13.45 | 08/11/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728620381 | CMS |
| Lilly USA, LLC | $13.72 | 10/07/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728627149 | CMS |
| PFIZER INC. | $18.44 | 08/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743621593 | CMS |
| Ultragenyx Pharmaceutical Inc. | $17.65 | 08/08/2020 | Food and Beverage | Undisputed | 01/23/2026 | 723161991 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.